Stock listing
BOATS:LYEL Lyell Immunopharma, Inc. Stock
US listing (BOATS) of Lyell Immunopharma, Inc. · home listing NASDAQ:LYEL
Follow Lyell Immunopharma, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:LYEL
$11.04 USD -0.27 (-2.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:LYEL
- Day range
- $10.80 – $11.40 USDOct 30, 2026
- Volume
- 113,258 sharesOct 30, 2026
- Market cap
- $270.5M USDAt the close on Oct 30, 2026 · price × 24.51M shares outstanding
- 52-week range
- $7.20 – $45.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.75M USDMedian day 128,453 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LYEL · Home | $11.04 USD | -0.265 (-2.3%) | 113,258 | $11.26 | $11.40 | $10.80 | $11.31 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:LYEL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.04 | -0.265 | -2.3% | $11.26 | $11.40 | $10.80 | 113,258 | |
| $11.31 | +0.375 | +3.4% | $11.00 | $11.62 | $11.00 | 149,218 | |
| $10.93 | +0.81 | +8.0% | $10.01 | $11.03 | $9.84 | 156,807 | |
| $10.12 | +0.81 | +8.7% | $9.34 | $10.14 | $9.26 | 127,906 | |
| $9.31 | -0.08 | -0.9% | $9.38 | $9.42 | $9.075 | 85,217 | |
| $9.39 | +0.01 | +0.1% | $9.33 | $9.445 | $9.05 | 101,600 | |
| $9.38 | -0.03 | -0.3% | $9.40 | $9.69 | $9.27 | 93,200 | |
| $9.41 | -0.29 | -3.0% | $9.65 | $10.12 | $9.29 | 118,300 | |
| $9.70 | +0.90 | +10.2% | $8.74 | $10.01 | $8.565 | 158,600 | |
| $8.80 | +0.68 | +8.4% | $8.00 | $9.05 | $7.92 | 212,900 | |
| $8.12 | -0.07 | -0.9% | $8.24 | $8.44 | $7.921 | 195,000 | |
| $8.19 | +0.20 | +2.5% | $8.00 | $8.44 | $7.76 | 325,000 | |
| $7.99 | +0.48 | +6.4% | $7.42 | $8.285 | $7.195 | 402,200 | |
| $7.51 | -0.76 | -9.2% | $8.27 | $8.27 | $7.39 | 187,200 | |
| $8.27 | -0.44 | -5.1% | $8.63 | $8.69 | $8.23 | 100,400 | |
| $8.71 | -0.08 | -0.9% | $8.72 | $9.10 | $8.615 | 106,800 | |
| $8.79 | +0.23 | +2.7% | $8.49 | $8.845 | $8.21 | 194,700 | |
| $8.56 | -0.05 | -0.6% | $8.48 | $8.95 | $8.38 | 184,700 | |
| $8.61 | -0.46 | -5.1% | $9.13 | $9.13 | $8.585 | 125,000 | |
| $9.07 | -0.19 | -2.1% | $9.27 | $9.31 | $8.66 | 129,400 | |
| $9.26 | -0.15 | -1.6% | $9.55 | $9.56 | $9.21 | 111,400 | |
| $9.41 | -0.38 | -3.9% | $9.80 | $9.97 | $9.36 | 115,200 | |
| $9.79 | +0.16 | +1.7% | $9.61 | $10.00 | $9.425 | 153,900 | |
| $9.63 | -0.11 | -1.1% | $9.74 | $9.74 | $9.445 | 140,800 | |
| $9.74 | -0.11 | -1.1% | $9.80 | $9.96 | $9.60 | 129,000 | |
| $9.85 | -0.27 | -2.7% | $10.16 | $10.16 | $9.81 | 108,900 | |
| $10.12 | -0.41 | -3.9% | $10.41 | $10.76 | $10.06 | 164,500 | |
| $10.53 | -0.62 | -5.6% | $11.05 | $11.05 | $10.32 | 161,500 | |
| $11.15 | +0.22 | +2.0% | $11.09 | $11.23 | $10.95 | 211,500 | |
| $10.93 | -0.08 | -0.7% | $11.02 | $11.18 | $10.60 | 142,600 | |
| $11.01 | +0.21 | +1.9% | $10.75 | $11.05 | $10.53 | 401,100 | |
| $10.80 | +0.025 | +0.2% | $11.01 | $11.06 | $10.60 | 133,000 | |
| $10.78 | -0.135 | -1.2% | $10.90 | $10.98 | $10.46 | 154,700 | |
| $10.91 | -0.42 | -3.7% | $11.29 | $11.29 | $10.55 | 184,100 | |
| $11.33 | -0.63 | -5.3% | $11.97 | $12.39 | $11.24 | 104,400 | |
| $11.96 | -0.24 | -2.0% | $12.41 | $13.00 | $11.70 | 152,200 | |
| $12.20 | -0.68 | -5.3% | $12.70 | $12.71 | $12.04 | 110,900 | |
| $12.88 | -0.65 | -4.8% | $13.52 | $13.82 | $12.71 | 101,600 | |
| $13.53 | -0.84 | -5.8% | $14.12 | $14.13 | $13.37 | 82,500 | |
| $14.37 | +0.05 | +0.3% | $14.29 | $14.68 | $13.92 | 54,100 | |
| $14.32 | -0.635 | -4.2% | $15.11 | $15.14 | $14.19 | 79,100 | |
| $14.96 | +0.43 | +3.0% | $14.49 | $14.97 | $14.25 | 56,900 | |
| $14.53 | +0.205 | +1.4% | $14.14 | $14.84 | $14.00 | 67,000 | |
| $14.32 | -0.21 | -1.4% | $14.51 | $14.71 | $14.14 | 62,800 | |
| $14.53 | -0.08 | -0.5% | $14.56 | $14.78 | $14.06 | 78,100 | |
| $14.61 | -0.19 | -1.3% | $14.67 | $15.02 | $14.33 | 88,400 | |
| $14.80 | -0.69 | -4.5% | $15.34 | $15.41 | $14.61 | 87,800 | |
| $15.49 | +0.75 | +5.1% | $15.02 | $15.68 | $14.92 | 103,000 | |
| $14.74 | -0.79 | -5.1% | $15.30 | $15.49 | $14.46 | 73,200 | |
| $15.53 | +0.18 | +1.2% | $15.54 | $16.16 | $15.20 | 104,900 | |
| $15.35 | -0.41 | -2.6% | $15.59 | $16.02 | $14.53 | 207,600 | |
| $15.76 | -0.03 | -0.2% | $16.02 | $17.15 | $15.66 | 171,000 | |
| $15.79 | +2.24 | +16.5% | $13.54 | $15.81 | $13.46 | 310,900 | |
| $13.55 | -0.40 | -2.9% | $13.86 | $13.93 | $13.39 | 132,500 | |
| $13.95 | +0.21 | +1.5% | $13.77 | $14.02 | $13.42 | 106,100 | |
| $13.74 | -0.43 | -3.0% | $14.20 | $14.41 | $13.70 | 89,000 | |
| $14.17 | -0.71 | -4.8% | $14.77 | $15.01 | $14.07 | 98,100 | |
| $14.88 | +0.55 | +3.8% | $14.33 | $15.52 | $14.32 | 134,518 | |
| $14.33 | -0.38 | -2.6% | $14.50 | $15.08 | $14.09 | 203,106 | |
| $14.71 | +0.50 | +3.5% | $14.00 | $15.09 | $13.95 | 111,000 | |
| $14.21 | +0.76 | +5.7% | $14.01 | $15.63 | $13.85 | 362,800 | |
| $13.45 | -0.15 | -1.1% | $13.50 | $13.98 | $13.20 | 484,700 | |
| $13.60 | +0.73 | +5.7% | $12.87 | $13.83 | $12.87 | 186,700 | |
| $12.87 | -0.07 | -0.5% | $13.05 | $13.15 | $12.71 | 86,000 | |
| $12.94 | -0.78 | -5.7% | $13.50 | $13.66 | $12.88 | 126,700 | |
| $13.72 | +0.75 | +5.8% | $12.98 | $13.74 | $12.82 | 197,900 |
- Ticker
- BOATS:LYEL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Lyell Immunopharma To Participate in November Investor Events
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 51 slides
Latest news
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
Sep 14, 2026
Closed $11.33 (-5.3%) on Sep 14, 2026
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
Sep 10, 2026
Closed $11.96 (-2.0%) on Sep 11, 2026
Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
Aug 6, 2026
Closed $14.71 (+3.5%) on Aug 7, 2026
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
Aug 6, 2026
Closed $14.71 (+3.5%) on Aug 7, 2026
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun 25, 2026
Closed $12.49 (-3.9%) on Jun 25, 2026
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
Jun 12, 2026
Closed $13.50 (-1.6%) on Jun 12, 2026
Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion
Jun 8, 2026
Closed $12.31 (+2.8%) on Jun 8, 2026
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
Jun 4, 2026
Closed $13.05 (+3.8%) on Jun 4, 2026
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
Jun 1, 2026
Closed $17.15 (-1.0%) on Jun 1, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 51 slides · September 2026
American Society of Hematology (ASH) 2025
Conference · 21 slides · Dec 7, 2025
American Society of Hematology (ASH) 2025
Conference · 13 slides · Dec 7, 2025
International Conference on Malignant Lymphoma (ICML) 2025
Conference · 11 slides · Jun 18, 2025
Lyell Immunopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 89 in all · newest Nov 2, 2026 · oldest 2021
- Decks
- 6 decks · latest September 2026
Where Lyell Immunopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LYEL · Home listing | NASDAQ | United States | USD |
| BOATS:LYEL · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lyell Immunopharma, Inc.